New information on a major player in chronic visceral leishmaniasis

October 4, 2017, Institut national de la recherche scientifique - INRS
New information on a major player in chronic visceral leishmaniasis
Credit: Institut national de la recherche scientifique - INRS

In an article in the latest issue of PLOS Pathogens, INRS professor Simona Stäger and her team show how the parasite Leishmania donovani uses a physiological response to low oxygen levels (hypoxia) to establish a chronic infection.

The parasite behind causes a chronic inflammation that enlarges the spleen and creates a hypoxic microenvironment. To compensate for the lack of oxygen and ensure their survival, cells adapt by inducing the expression of the transcription factor HIF-1α, the master regulator of the cellular response to hypoxia.

Professor Stäger and her team have demonstrated the effect of this key regulator on the function of monocytes and macrophages during viceral leishmaniasis, the most severe form of a tropical disease that affects millions of people around the world. These cells are the main targets of the parasite L. donovani

"Our lab work demonstrates that HIF-1α plays a key role in the establishment of chronic Leishmania infections by reducing the capacity of monocytes and macrophages to kill the parasite. We also found that HIF-1α gives these cells immunosuppressant properties," explains Professor Stäger.

Explore further: Mechanisms triggering excess antibody production during chronic infection

More information: Akil Hammami et al, HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006616

Related Stories

Mechanisms triggering excess antibody production during chronic infection

July 12, 2016
Some autoimmune diseases and persistent infections are characterized by high levels of antibodies in the blood. But what are the causes of this hypergammaglobulinemia? A team headed by INRS's Professor Simona Stäger has ...

Meeting a microbe in the morning or in the evening: Is it all the same?

September 8, 2017
Does the time of day matter when our body is infected by a parasite? According to new research from McGill University, it matters a great deal.

How the leishmania parasite sabotages the immune response

October 12, 2016
An international collaborative of researchers has identified a mechanism that allows the leishmania parasite, which causes leishmaniasis, to evade the immune system and thereby produce infection. The study, published in Immunity, ...

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.